Skip to main content

Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome.

Publication ,  Journal Article
Davies, RW; Fiksinski, AM; Breetvelt, EJ; Williams, NM; Hooper, SR; Monfeuga, T; Bassett, AS; Owen, MJ; Gur, RE; Morrow, BE; Swillen, A ...
Published in: Nat Med
December 2020

The 22q11.2 deletion syndrome (22q11DS) is associated with a 20-25% risk of schizophrenia. In a cohort of 962 individuals with 22q11DS, we examined the shared genetic basis between schizophrenia and schizophrenia-related early trajectory phenotypes: sub-threshold symptoms of psychosis, low baseline intellectual functioning and cognitive decline. We studied the association of these phenotypes with two polygenic scores, derived for schizophrenia and intelligence, and evaluated their use for individual risk prediction in 22q11DS. Polygenic scores were not only associated with schizophrenia and baseline intelligence quotient (IQ), respectively, but schizophrenia polygenic score was also significantly associated with cognitive (verbal IQ) decline and nominally associated with sub-threshold psychosis. Furthermore, in comparing the tail-end deciles of the schizophrenia and IQ polygenic score distributions, 33% versus 9% of individuals with 22q11DS had schizophrenia, and 63% versus 24% of individuals had intellectual disability. Collectively, these data show a shared genetic basis for schizophrenia and schizophrenia-related phenotypes and also highlight the future potential of polygenic scores for risk stratification among individuals with highly, but incompletely, penetrant genetic variants.

Duke Scholars

Published In

Nat Med

DOI

EISSN

1546-170X

Publication Date

December 2020

Volume

26

Issue

12

Start / End Page

1912 / 1918

Location

United States

Related Subject Headings

  • Young Adult
  • Schizophrenia
  • Risk Factors
  • Phenotype
  • Multifactorial Inheritance
  • Middle Aged
  • Male
  • Intellectual Disability
  • Immunology
  • Humans
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davies, R. W., Fiksinski, A. M., Breetvelt, E. J., Williams, N. M., Hooper, S. R., Monfeuga, T., … Vorstman, J. A. S. (2020). Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat Med, 26(12), 1912–1918. https://doi.org/10.1038/s41591-020-1103-1
Davies, Robert W., Ania M. Fiksinski, Elemi J. Breetvelt, Nigel M. Williams, Stephen R. Hooper, Thomas Monfeuga, Anne S. Bassett, et al. “Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome.Nat Med 26, no. 12 (December 2020): 1912–18. https://doi.org/10.1038/s41591-020-1103-1.
Davies RW, Fiksinski AM, Breetvelt EJ, Williams NM, Hooper SR, Monfeuga T, et al. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat Med. 2020 Dec;26(12):1912–8.
Davies, Robert W., et al. “Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome.Nat Med, vol. 26, no. 12, Dec. 2020, pp. 1912–18. Pubmed, doi:10.1038/s41591-020-1103-1.
Davies RW, Fiksinski AM, Breetvelt EJ, Williams NM, Hooper SR, Monfeuga T, Bassett AS, Owen MJ, Gur RE, Morrow BE, McDonald-McGinn DM, Swillen A, Chow EWC, van den Bree M, Emanuel BS, Vermeesch JR, van Amelsvoort T, Arango C, Armando M, Campbell LE, Cubells JF, Eliez S, Garcia-Minaur S, Gothelf D, Kates WR, Murphy KC, Murphy CM, Murphy DG, Philip N, Repetto GM, Shashi V, Simon TJ, Suñer DH, Vicari S, Scherer SW, International 22q11.2 Brain and Behavior Consortium, Bearden CE, Vorstman JAS. Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndrome. Nat Med. 2020 Dec;26(12):1912–1918.

Published In

Nat Med

DOI

EISSN

1546-170X

Publication Date

December 2020

Volume

26

Issue

12

Start / End Page

1912 / 1918

Location

United States

Related Subject Headings

  • Young Adult
  • Schizophrenia
  • Risk Factors
  • Phenotype
  • Multifactorial Inheritance
  • Middle Aged
  • Male
  • Intellectual Disability
  • Immunology
  • Humans